1. Home
  2. LIPO

LIPO

Lipella Pharmaceuticals Inc.

Logo Lipella Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

Founded: 2005 Country:
United States
United States
Employees: N/A City: PITTSBURGH
Market Cap: 4.8M IPO Year: 2022
Target Price: $2.00 AVG Volume (30 days): 60.9K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.77 EPS Growth: N/A
52 Week Low/High: $0.64 - $2.71 Next Earning Date: 05-13-2024
Revenue: $449,617 Revenue Growth: 144.15%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: